Florida Cancer Specialists & Research Institute Welcomes Dr. Adewale A. Fawole

  • March 2, 2018

Lake & Sumter Counties, FL – March 1, 2018. . . Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, is pleased to announce that Adewale Fawole, MD, has joined the practice as a hospitalist and will be seeing FCS patients who require hospitalization.

FCS CEO Brad Prechtl, MBA said, “Dr. Fawole will bring great expertise and stature as a Hospitalist in Lake and Sumter counties, focusing on bridging the continuum of care we offer patients who must be hospitalized. We are very pleased to have him join the FCS family.”

Dr. William Harwin, Founder and President of FCS, added, “Dr. Fawole comes to us with excellent credentials and I know he will be a great complement to our physicians in Lake and Sumter counties, allowing us to better serve our patients.”

Dr. Adewale Fawole is a well-qualified, compassionate, board-certified Hematologist and Medical Oncologist. After completing his Internal Medicine Residency training at the Cleveland Clinic in Ohio, Dr. Fawole pursued Hematology and Medical Oncology Fellowship training at the Oakland University William Beaumont School of Medicine in Michigan, where he served as a Chief Fellow. In recognition of his dedication to the care of cancer patients, Dr. Fawole received the Freeman Wilner Foundation’s Compassionate Care Award.

Prior to joining Florida Cancer Specialists, Dr. Fawole served as an Assistant Professor and Attending Physician in the Division of Hematology at The Ohio State University Comprehensive Cancer Center (OSUCC)-James Cancer Hospital in Columbus, where he mentored upcoming physicians while also collaborating with other specialists. Dr. Fawole’s research work included colon cancer, lymphoma, brain cancer, multiple myeloma and other cancer-related conditions. His works have been published in numerous peer-reviewed journals, including the Journal of Clinical Oncology.

Dr. Fawole has broad experience in the treatment of cancers of the breasts, lung, prostate, GI system, Head & Neck, and central nervous system. He also treats patients with lymphomas, multiple myeloma, anemia, blood clots and other blood disorders. He focuses on providing patients with personalized treatment plans that fit their cancer without neglecting their quality of lives, and their loved ones. He uses the current knowledge in cancer genetics to prevent cancer in patients and their families. When he is not at work, Dr. Fawole enjoys spending time with his wife and three lovely children, traveling, reading and playing soccer.
About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 220 physicians, 180 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state’s leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast from Jacksonville/Fleming Island to Palm Beach County.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

* Prior to approval
Florida Cancer Specialists & Research Institute

Shelly Glenn, Chief Marketing & Sales Officer – SGlenn@FLCancer.com

Chris Wilkerson – cwilkerson@chappellroberts.com

Ganick Communications, Inc.
Elaine Ganick – elaine@ganick.com

Who’s Online

There are no users currently online